NCT01441947 Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer Status COMPLETED Phase PHASE2
NCT01428219 Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone Status TERMINATED Phase PHASE2
NCT01347788 Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT01068782 Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse Status TERMINATED Phase PHASE2
NCT00940225 Study of Cabozantinib (XL184) in Adults With Advanced Malignancies Status COMPLETED Phase PHASE2